{"id":"https://openalex.org/W1978224809","doi":"https://doi.org/10.2165/00019053-199508020-00008","title":"Methodological and Conduct Principles for Pharmacoeconomic Research","display_name":"Methodological and Conduct Principles for Pharmacoeconomic Research","publication_year":1995,"publication_date":"1995-08-01","ids":{"openalex":"https://openalex.org/W1978224809","doi":"https://doi.org/10.2165/00019053-199508020-00008","mag":"1978224809","pmid":"https://pubmed.ncbi.nlm.nih.gov/10155611"},"language":"en","primary_location":{"id":"doi:10.2165/00019053-199508020-00008","doi":"https://doi.org/10.2165/00019053-199508020-00008","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00019053-199508020-00008","pdf_url":null,"source":{"id":"https://openalex.org/S43019230","display_name":"PharmacoEconomics","issn_l":"1170-7690","issn":["1170-7690","1179-2027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009854505","display_name":"Kevan Clemens","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevan Clemens","raw_affiliation_strings":["Roche Pharmaceuticals, Palo Alto, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Pharmaceuticals, Palo Alto, California, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113534454","display_name":"Raymond J. Townsend","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raymond Townsend","raw_affiliation_strings":["Glaxo Inc., Research Triangle Park, North California, USA","Glaxo, Inc, Research Triangle Park,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxo Inc., Research Triangle Park, North California, USA","institution_ids":[]},{"raw_affiliation_string":"Glaxo, Inc, Research Triangle Park,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017878020","display_name":"Faye A. Luscombe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Faye Luscombe","raw_affiliation_strings":["Parke-Davis, Ann Arbor, Michigan, USA","Parke-Davis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Parke-Davis, Ann Arbor, Michigan, USA","institution_ids":[]},{"raw_affiliation_string":"Parke-Davis","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001156357","display_name":"Josephine Mauskopf","orcid":"https://orcid.org/0000-0002-6098-5548","observed_orcids":["https://orcid.org/0000-0002-6098-5548"]},"institutions":[{"id":"https://openalex.org/I2800129774","display_name":"Sigma Xi","ror":"https://ror.org/04nmj5x57","country_code":"US","type":"other","lineage":["https://openalex.org/I2800129774"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Josephine Mauskopf","raw_affiliation_strings":["Burroughs Wellcome Co., Research Triangle Park, North California, USA","Burroughs Wellcome Co., Research Triangle Park"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Burroughs Wellcome Co., Research Triangle Park, North California, USA","institution_ids":[]},{"raw_affiliation_string":"Burroughs Wellcome Co., Research Triangle Park","institution_ids":["https://openalex.org/I2800129774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108418260","display_name":"Jane T. Osterhaus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jane Osterhaus","raw_affiliation_strings":["Glaxo Inc., Research Triangle Park, North California, USA","Glaxo, Inc, Research Triangle Park,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxo Inc., Research Triangle Park, North California, USA","institution_ids":[]},{"raw_affiliation_string":"Glaxo, Inc, Research Triangle Park,","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061760107","display_name":"Joel D. Bobula","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1335914248","display_name":"Pharmaceutical Research and Manufacturers of America","ror":"https://ror.org/01z88k350","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1335914248"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel Bobula","raw_affiliation_strings":["Pharmaceutical Research and Manufacturers of America (PhRMA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research and Manufacturers of America (PhRMA","institution_ids":["https://openalex.org/I1335914248"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":null,"fwci":33.9551,"has_fulltext":false,"cited_by_count":88,"citation_normalized_percentile":{"value":0.99681375,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"8","issue":"2","first_page":"169","last_page":"174"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.007400000002235174,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/research-methodology","display_name":"research methodology","score":0.5490000247955322},{"id":"https://openalex.org/keywords/research-reporting","display_name":"research reporting","score":0.6970000267028809},{"id":"https://openalex.org/keywords/scientific-integrity","display_name":"scientific integrity","score":0.7519999742507935},{"id":"https://openalex.org/keywords/transparency","display_name":"transparency","score":0.6269999742507935},{"id":"https://openalex.org/keywords/phrma","display_name":"PhRMA","score":0.6010000109672546}],"concepts":[{"id":"https://openalex.org/C2780233690","wikidata":"https://www.wikidata.org/wiki/Q535347","display_name":"Transparency (behavior)","level":2,"score":0.726591944694519},{"id":"https://openalex.org/C524218345","wikidata":"https://www.wikidata.org/wiki/Q31218","display_name":"Health economics","level":3,"score":0.6314735412597656},{"id":"https://openalex.org/C2777276634","wikidata":"https://www.wikidata.org/wiki/Q211067","display_name":"Conflict of interest","level":2,"score":0.5237628817558289},{"id":"https://openalex.org/C2993209047","wikidata":"https://www.wikidata.org/wiki/Q91248609","display_name":"Scientific integrity","level":2,"score":0.47964006662368774},{"id":"https://openalex.org/C2778091340","wikidata":"https://www.wikidata.org/wiki/Q15749950","display_name":"Quality of Life Research","level":3,"score":0.46430686116218567},{"id":"https://openalex.org/C137992405","wikidata":"https://www.wikidata.org/wiki/Q1137608","display_name":"Health administration","level":3,"score":0.4604853093624115},{"id":"https://openalex.org/C39920170","wikidata":"https://www.wikidata.org/wiki/Q693083","display_name":"Soundness","level":2,"score":0.4414011836051941},{"id":"https://openalex.org/C71008984","wikidata":"https://www.wikidata.org/wiki/Q2890076","display_name":"Rigour","level":2,"score":0.41963496804237366},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3855407238006592},{"id":"https://openalex.org/C539667460","wikidata":"https://www.wikidata.org/wiki/Q2414942","display_name":"Management science","level":1,"score":0.3718745708465576},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.3553970456123352},{"id":"https://openalex.org/C55587333","wikidata":"https://www.wikidata.org/wiki/Q1133029","display_name":"Engineering ethics","level":1,"score":0.33584868907928467},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.21873325109481812},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.17067936062812805},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.14683127403259277},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.1328793466091156},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.12343814969062805},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.10253870487213135},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D003142","descriptor_name":"Communication","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003365","descriptor_name":"Costs and Cost Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012107","descriptor_name":"Research Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017850","descriptor_name":"Economics, Pharmaceutical","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2165/00019053-199508020-00008","doi":"https://doi.org/10.2165/00019053-199508020-00008","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00019053-199508020-00008","pdf_url":null,"source":{"id":"https://openalex.org/S43019230","display_name":"PharmacoEconomics","issn_l":"1170-7690","issn":["1170-7690","1179-2027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"journal-article"},{"id":"pmid:10155611","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10155611","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"Guideline"}],"best_oa_location":null,"sustainable_development_goals":[],"sustainable_development_goals_aurora":[{"score":0.550000011920929,"id":"https://metadata.un.org/sdg/17","display_name":"Partnerships for the goals"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W103865059","https://openalex.org/W1491571181","https://openalex.org/W1594737140","https://openalex.org/W1966814352","https://openalex.org/W1966922991","https://openalex.org/W1970082900","https://openalex.org/W1993053949","https://openalex.org/W2009294093","https://openalex.org/W2034908522","https://openalex.org/W2052015286","https://openalex.org/W2060454355","https://openalex.org/W2061047185","https://openalex.org/W2067550511","https://openalex.org/W2071796477","https://openalex.org/W2101499551","https://openalex.org/W2128191136","https://openalex.org/W2165613296","https://openalex.org/W2170149140","https://openalex.org/W2315694873","https://openalex.org/W2338601379","https://openalex.org/W2945611040","https://openalex.org/W3155027651"],"related_works":["https://openalex.org/W2129233436","https://openalex.org/W2042217487","https://openalex.org/W2466059274","https://openalex.org/W2090619689","https://openalex.org/W2170149140","https://openalex.org/W2054436885","https://openalex.org/W1536008645","https://openalex.org/W2149076162","https://openalex.org/W2065626327","https://openalex.org/W1498045318"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}